TERT-BUTYLBICYCLOORTHO[H-3]BENZOATE (H-3-TBOB) TOXICOKINETICS AND DISPOSITION IN RATS

被引:1
|
作者
ZIERER, R
SEIFERT, J
机构
[1] Department of Agricultural Biochemistry, University of Hawaii, Honolulu, HI, 96822
关键词
D O I
10.3109/00498259109039523
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Toxicokinetics of tert-butylbicycloortho[H-3]benzoate (H-3-TBOB) administered into the right atrium of rat heart can be described by the biexponential equation: c(t) = Ae-1.6t + Be-0.013t. 2. The fast initial phase of H-3-TBOB decline in blood (t1/2 = 0.5 min) is due to its absorption by lungs. H-3-TBOB is then transferred into liver, the primary organ of its metabolic detoxication. The high apparent distribution volumes for H-3-TBOB (1.3 and 7.1 l/kg for the initial and the terminal phase, respectively) are probably due to its lipophilicity and partitioning into lipoid tissue membranes. 3. Acid-labile TBOB is not completely hydrolysed in gastric fluid. A portion of H-3-TBOB administered into the stomach is absorbed within 3 min into the circulatory system. 4. Intra-arterially administered H-3-TBOB distributes in the brain in a lateral and regional pattern. 5. Two types of H-3-TBOB metabolites are excreted in urine and faeces. Both are more polar than the parent compound. The major components of the fraction were tentatively identified as hippuric and benzoic acid.
引用
收藏
页码:839 / 846
页数:8
相关论文
共 50 条
  • [31] FOLATES - EPILEPTOGENIC EFFECTS AND ENHANCING EFFECTS ON [H-3] TBOB BINDING TO THE GABA-A-RECEPTOR COMPLEX
    VANRIJN, CM
    VANDERVELDEN, TJAM
    DEMIRANDA, JFR
    FEENSTRA, MGP
    HIEL, JAP
    HOMMES, OR
    EPILEPSY RESEARCH, 1990, 5 (03) : 199 - 208
  • [32] COMPARISON OF [H-3] N-METHYLSCOPOLAMINE ([H-3] NMS), [H-3] N-METHYLQUINUCLIDINYL BENZILATE ([H-3] NMEQNB) AND [H-3] QUINUCLIDINYL BENZILATE ([H-3]QNB) BINDING IN RAT-TISSUE HOMOGENATES
    LEE, NH
    RAMKUMAR, V
    ELFAKAHANY, EE
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 391 - 391
  • [33] TRANSPORT OF MATERNAL [H-3] MELATONIN TO SUCKLING RATS AND FATE OF [H-3] MELATONIN IN NEONATAL RAT
    REPPERT, SM
    KLEIN, DC
    PHARMACOLOGIST, 1977, 19 (02): : 218 - 218
  • [34] TRANSPORT OF MATERNAL [H-3]MELATONIN TO SUCKLING RATS AND FATE OF [H-3]MELATONIN IN NEONATAL RAT
    REPPERT, SM
    KLEIN, DC
    ENDOCRINOLOGY, 1978, 102 (02) : 582 - 588
  • [35] ANTIANGINAL ARYLALKYLAMINES AND SODIUM-CHANNELS - [H-3] BATRACHOTOXININ-A 20-ALPHA-BENZOATE AND [H-3] TETRACAINE BINDING
    GRIMA, M
    SCHWARTZ, J
    SPACH, MO
    VELLY, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1986, 89 (04) : 641 - 646
  • [36] ACCURATE CROSS-SECTIONS FOR H-3(P,P)H-3, H-3(P,D)H-2, AND H-3(P,HE-3)N
    DETCH, JL
    HUTSON, RL
    JARMIE, N
    BULLETIN OF THE AMERICAN PHYSICAL SOCIETY, 1970, 15 (01): : 22 - &
  • [37] Integrals required for computing the energy of H-3 and of H-3(+)
    Hirschfelder, JO
    Weygandt, CN
    JOURNAL OF CHEMICAL PHYSICS, 1938, 6 (12): : 806 - 810
  • [38] DISPOSITION OF FRACTIONATED H-3-HEPARIN IN RATS
    HORI, K
    WATANABE, J
    OZEKI, S
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1985, 8 (06): : S135 - S135
  • [39] DISPOSITION AND METABOLISM OF [GLICLAZIDE-H-3 IN RATS
    MIYAZAKI, H
    FUJII, T
    YOSHIDA, K
    ARAKAWA, S
    FURUKAWA, H
    SUZUKI, H
    KAGEMOTO, A
    HASHIMOTO, M
    TAMAKI, N
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1983, 8 (02) : 117 - 131
  • [40] DISTRIBUTION OF [H-3]DIISOPROPYLFLUOROPHOSPHATE, [H-3] SOMAN, [H-3] SARIN, AND THEIR METABOLITES IN MOUSE-BRAIN
    LITTLE, PJ
    SCIMECA, JA
    MARTIN, BR
    DRUG METABOLISM AND DISPOSITION, 1988, 16 (04) : 515 - 520